Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Liofilchem™ ComASP Oritavancin
SDP

Catalog No. 22778093
Click to view available options
Quantity:
4 Systems (panels)
Non-hazardous according to current legislation but fall within the specific field of application where a safety data sheet must be supplied because they can cause phenomena of sensitisation in sensitive subjects if they come into contact with the skin.
Non-hazardous according to current legislation but fall within the specific field of application where a safety data sheet must be supplied because they can cause phenomena of sensitisation in sensitive subjects if they come into contact with the skin.

This system is a compact version of the broth microdilution (BMD) reference method allowing to perform the antimicrobial susceptibility testing of Oritavancin as recommended by international standards (i.e. CLSI, EUCAST, ISO) but in a simpler and less time-consuming way.

  • 4 Systems (panels) of ComASP™ Oritavancin 0.001-16 (panels individually packed in foil with silica gel desiccant)
  • 8 Tubes of Mueller Hinton II Broth w P80 (3.6 mL)
  • Sealing Film

Specifications

Antimicrobial Agents Oritavancin
Concentration 0.001 to 16 μg/mL
Content And Storage Store ComASP™ Oritavancin 0.001 to 16 at 2°C to 8°C in the original packaging. Once an envelope is opened the panel should be used within 7 days and stored at 2°C to 8°C. Keep away from direct sunlight and direct heat
Product Type Panel
Sterility Non-sterile
Test Type Media Testing
Quantity 4 Systems (panels)
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.